[Leprechaunism (Donohue syndrome)].
Morooka
Keiichi
K
First Department of Pediatrics, Toho University School of Medicine.
D000015:Abnormalities, Multiple / Q000188:drug therapy / Q000209:etiology; D000052:Acanthosis Nigricans / Q000188:drug therapy / Q000209:etiology; D002239:Carbohydrate Metabolism, Inborn Errors / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006130:Growth Disorders / Q000188:drug therapy / Q000209:etiology; D006628:Hirsutism / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007223:Infant; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D009154:Mutation; D011505:Protein-Tyrosine Kinases / Q000172:deficiency; D011972:Receptor, Insulin / Q000235:genetics / Q000378:metabolism; D011994:Recombinant Proteins / Q000627:therapeutic use; D013577:Syndrome
D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I; D011505:Protein-Tyrosine Kinases; D011972:Receptor, Insulin